News

November 17, 2017November 17, 2017

BCL6 Levels Can Predict Low IVF Success Rates

News

Researchers have found that high levels of the protein BCL6 in women with unexplained infertility (UI), for which endometriosis is a major cause, were strongly associated with poor reproductive results ... Read more

November 15, 2017November 15, 2017

Relugolix, Potential Endometriosis Therapy, Seen to Ease Pain of Uterine Fibroids in Phase 3 Study

News

Relugolix robustly lowered pain in a Phase 3 study in Japan of women with uterine fibroids, further supporting it as a potential treatment for women with these fibroids or endometriosis, ... Read more

November 13, 2017November 13, 2017

Elagolix Improves Uterine Fibroid Symptoms with and Without Add-Back Therapy, Trials Show

News

AbbVie presented data from two Phase 2 clinical trials showing that elagolix, with or without add-back therapy, led to a rapid reduction of heavy menstrual bleeding compared to a placebo ... Read more

November 8, 2017November 8, 2017

Enrollment Complete in EDELWEISS Phase 2b Trial of OBE2109 for Endometriosis Pain

News

ObsEva announced the completion of patient enrollment in a Phase 2b clinical trial to evaluate OBE2109, an oral gonadotropin releasing hormone (GnRH) receptor antagonist, for the treatment of endometriosis-associated pain. The ... Read more

November 6, 2017

Elagolix Seen to Lessen Pain and Spread of Endometriosis in Yearlong Phase 3 Studies

News

Results of two Phase 3 extension studies showed that one year of treatment with elagolix could reduce pelvic pain, prevent proliferation of endometrium tissue, and improve quality of live in ... Read more

November 1, 2017November 1, 2017

Phase 3 Chinese Study Shows Visanne Effective at Reducing Endometriosis Pain

News

A Phase 3 trial has shown that daily administration of Visanne (dienogest) is safe and can significantly reduce endometriosis-associated pain in Chinese adult women. The findings further demonstrate the therapeutic potential ... Read more

October 30, 2017October 30, 2017

AbbVie’s Elagolix Wins FDA Priority Review to Manage Endometriosis with Associated Pain

News

The U.S. Food and Drug Administration (FDA) has granted priority review to AbbVie’s investigational medicine, Elagolix — formerly known as ABT-620 — for managing endometriosis with associated pain. Elagolix is an oral gonadotropin-releasing ... Read more

October 27, 2017October 27, 2017

Researcher Swims English Channel to Raise Endometriosis Awareness

News

Emma Watson, PhD, operations manager for the Earth, Science, and Engineering Department at the Imperial College London (ICL), swam the English Channel to raise awareness and funds for endometriosis. An ... Read more

October 25, 2017

Birth Records Show Link Between Endometriosis and Pregnancy Complications, Analysis Finds

News

Women with endometriosis are at a higher risk of obstetric complications, including miscarriages, cesarean delivery, and premature births, according to an analysis of birth records. The study, titled “Endometriosis and ... Read more

October 18, 2017

Surgical Treatment of Endometriosis Has Poor 1-Year Outcome, Study Shows

News

Researchers found that treatment of endometriosis by completely or partially removing the uterus (hysterectomy) or removing lesions via laparoscopy surgery can promote very different outcomes. Surgical treatment of endometriosis can ... Read more